Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DEB - Dystrophic Epidermolysis Bullosa”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02984085
What this trial is testing

Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Holostem s.r.l. 3
Testing effectiveness (Phase 2)Study completedNCT03012191
What this trial is testing

Gentamicin for RDEB

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
University of Southern California 6
Testing effectiveness (Phase 2)UnknownNCT05157958
What this trial is testing

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Anterogen Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT01538862
What this trial is testing

Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Vanderbilt University Medical Center 7
Testing effectiveness (Phase 2)Looking for participantsNCT06731933
What this trial is testing

Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin

Who this might be right for
Squamous Cell Carcinoma
Stanford University 16
Large-scale testing (Phase 3)Study completedNCT04227106
What this trial is testing

Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics, Inc 11
Post-approval studies (Phase 4)Not Yet RecruitingNCT07717736
What this trial is testing

Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds

Who this might be right for
Epidermolysis Bullosa (EB)Recessive Dystrophic Epidermolysis Bullosa (RDEB)Dystrophic Epidermolysis Bullosa (DEB)
Abeona Therapeutics, Inc 100
Large-scale testing (Phase 3)Looking for participantsNCT07016750
What this trial is testing

A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa+1 more
Krystal Biotech, Inc. 16
Testing effectiveness (Phase 2)Looking for participantsNCT06594393
What this trial is testing

TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

Who this might be right for
Epidermolysis Bullosa (EB)Dystrophic Epidermolysis BullosaJunctional Epidermolysis Bullosa
Xinnate AB 32
Not applicableEnded earlyNCT00478244
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Masonic Cancer Center, University of Minnesota 7
Large-scale testing (Phase 3)Study completedNCT04491604
What this trial is testing

Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB

Who this might be right for
Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT03752905
What this trial is testing

A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Phoenix Tissue Repair, Inc. 12
Early research (Phase 1)Study completedNCT05378997
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.

Who this might be right for
BlisterWound of SkinEpidermolysis Bullosa+1 more
Xinnate AB 35
Not applicableActive Not RecruitingNCT05843994
What this trial is testing

Artificial Intelligence Patient App for RDEB SCCs

Who this might be right for
Epidermolysis Bullosa Dystrophica
Northwestern University 20
Not applicableEnded earlyNCT00533572
What this trial is testing

Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer

Who this might be right for
Epidermolysis Bullosa Dystrophica
Stanford University 1
Large-scale testing (Phase 3)UnknownNCT02286427
What this trial is testing

A Comparative Study of the Healing of Chronic Ulcers of Recessive Epidermolysis Bullosa : Dressing vs Amniotic Membrane

Who this might be right for
Epidermolysis Bullosa Dystrophica, RecessiveUlcer
Assistance Publique - Hôpitaux de Paris 22
Testing effectiveness (Phase 2)Ended earlyNCT03578029
What this trial is testing

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

Who this might be right for
Junctional Epidermolysis BullosaDystrophic Epidermolysis Bullosa
Lenus Therapeutics, LLC 4
Not applicableWithdrawnNCT04214002
What this trial is testing

The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Who this might be right for
Dystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc.
Early research (Phase 1)Study completedNCT02493816
What this trial is testing

Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
King's College London 5
Testing effectiveness (Phase 2)UnknownNCT03392909
What this trial is testing

Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
University of Southern California 9
Next Page